Wells Fargo’s Alpha Tau Medical DRTS Stock Holding History

Wells Fargo’s Portfolio DRTS Stock Details DRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.33M	Buy	105,850 +56,550	+115%	+$513K	﹤0.01%	3916
2026 Q1	$349K	Buy	49,300 +25,800	+110%	+$182K	﹤0.01%	4343
2025 Q4	$116K	Buy	23,500 +17,500	+292%	+$73.8K	﹤0.01%	5322
2025 Q3	$27.1K	Buy	6,000 +3,500	+140%	+$11.9K	﹤0.01%	5720
2025 Q2	$7.8K	Buy	+2,500	New	+$7.04K	﹤0.01%	6010
2024 Q2	–	Sell	-10,556	Closed	-$31.1K	–	7038
2024 Q1	$31.1K	Sell	10,556 -250	-2%	-$768	﹤0.01%	5435
2023 Q4	$32.5K	Hold	10,806	–	–	﹤0.01%	5442
2023 Q3	$41K	Hold	10,806	–	–	﹤0.01%	5282
2023 Q2	$47.2K	Hold	10,806	–	–	﹤0.01%	5454
2023 Q1	$31K	Hold	10,806	–	–	﹤0.01%	5433
2022 Q4	$34.4K	Hold	10,806	–	–	﹤0.01%	5029
2022 Q3	$63K	Buy	+10,806	New	+$95.3K	﹤0.01%	4836

Other funds holding DRTS

GIA

Gem Investment Advisors Teaneck, New Jersey $163M AUM

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Aquamarine Financial George Town $1.81B AUM 38.21% 1-Year Est. Return

Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

Wells Fargo's DRTS Position: Q2 2026 in Review

Wells Fargo increased its Alpha Tau Medical (DRTS) stake by 115% in Q2 2026, buying an estimated $513K and bringing the position to 105,850 shares worth $1.33M. The position accounts for ﹤0.01% of the portfolio, ranked #3916.

Wells Fargo first reported a position in DRTS in Q3 2022 and has held it in 12 quarters since. 74 funds tracked by Wall St. Rank hold DRTS as of Q2 2026.

Wells Fargo held 105,850 shares of Alpha Tau Medical worth $1.33M as of Q2 2026.
Wells Fargo bought 56,550 Alpha Tau Medical shares in Q2 2026, an estimated $513K.
Alpha Tau Medical made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #3916 holding.
Wells Fargo first reported a position in Alpha Tau Medical in Q3 2022 and has held it in 12 quarters since.
74 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.